Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
926
QVC Group, Inc. Series A Common Stock
QVCGA
$87.4M
| $22M | 0.01% |
269,859
+176,041
| +188% | +$14.3M |
|
927
Procore
PCOR
$10.6B
| $21.8M | 0.01% |
462,453
-58,326
| -11% | -$2.75M |
|
928
Dropbox
DBX
$8.34B
| $21.8M | 0.01% |
974,264
+773,244
| +385% | +$17.3M |
|
929
Cenovus Energy
CVE
$30.4B
| $21.8M | 0.01% |
1,122,524
+1,106,476
| +6,895% | +$21.5M |
|
930
Caterpillar
CAT
$202B
| $21.8M | 0.01% |
90,902
-10,835
| -11% | -$2.6M |
|
931
TransAlta
TAC
$3.75B
| $21.7M | 0.01% |
2,425,621
+1,777,039
| +274% | +$15.9M |
|
|
EVRI
932
DELISTED
Everi Holdings
EVRI
| $21.6M | 0.01% |
1,508,114
-1,122,063
| -43% | -$16.1M |
|
933
Roku
ROKU
$14.2B
| $21.6M | 0.01% |
531,147
+465,184
| +705% | +$18.9M |
|
934
STAAR Surgical
STAA
$1.39B
| $21.6M | 0.01% |
444,766
+261,964
| +143% | +$12.7M |
|
935
Axos Financial
AX
$5.21B
| $21.6M | 0.01% |
564,055
-58,949
| -9% | -$2.25M |
|
936
Warner Music
WMG
$17.8B
| $21.5M | 0.01% |
614,358
-575,820
| -48% | -$20.2M |
|
937
Castle Biosciences
CSTL
$660M
| $21.5M | 0.01% |
913,375
-48,966
| -5% | -$1.15M |
|
938
GFL Environmental
GFL
$17.5B
| $21.5M | 0.01% |
734,740
+61,994
| +9% | +$1.81M |
|
939
Mersana Therapeutics
MRSN
$37.3M
| $21.5M | 0.01% |
146,541
-4,826
| -3% | -$707K |
|
940
Idacorp
IDA
$6.79B
| $21.5M | 0.01% |
199,008
-2,261
| -1% | -$244K |
|
941
Vera Therapeutics
VERA
$1.57B
| $21.5M | 0.01% |
1,108,649
+711,721
| +179% | +$13.8M |
|
|
UCB
942
United Community Banks, Inc.
UCB
$3.97B
| $21.4M | 0.01% |
633,177
+445,387
| +237% | +$15.1M |
|
943
Myriad Genetics
MYGN
$715M
| $21.4M | 0.01% |
1,472,416
+206,181
| +16% | +$2.99M |
|
944
TransDigm Group
TDG
$72.9B
| $21.4M | 0.01% |
33,918
-272,604
| -89% | -$172M |
|
945
AbbVie
ABBV
$389B
| $21.3M | 0.01% |
132,054
-505,224
| -79% | -$81.6M |
|
946
Jack in the Box
JACK
$342M
| $21.3M | 0.01% |
311,701
+244,788
| +366% | +$16.7M |
|
947
Live Nation Entertainment
LYV
$40.4B
| $21.2M | 0.01% |
304,677
-238,292
| -44% | -$16.6M |
|
948
Schneider National
SNDR
$4.3B
| $21.2M | 0.01% |
907,449
+18,597
| +2% | +$435K |
|
949
Werner Enterprises
WERN
$1.72B
| $21.2M | 0.01% |
526,972
+258,893
| +97% | +$10.4M |
|
950
CareTrust REIT
CTRE
$7.62B
| $21.2M | 0.01% |
1,140,243
+914,588
| +405% | +$17M |
|